• Kv1.3 Blockade in T Cell Immunity: Psora 4 and the New Front

  2026-06-13

  This thought-leadership article delves into the mechanistic underpinnings and translational strategies for targeting Kv1.3 channels in T cell-mediated immunity, spotlighting Psora 4 as a next-generation research tool. Integrating recent insights on channel regulation by KCNE4 and practical workflow guidance, we chart a path for translational researchers seeking precision immunomodulation in autoimmunity and inflammatory disease models.

• KR-12 Human Antimicrobial Peptide: Applied Workflows & Insig

  2026-06-12

  KR-12, the smallest active fragment of LL-37, is reshaping infection and inflammation research with its potent and selective antimicrobial, anti-biofilm, and immunomodulatory actions. Explore protocol-ready workflows, comparative data, and troubleshooting strategies to maximize the impact of KR-12 (human) TFA from APExBIO in translational and mechanistic studies.

• Simulation-Guided Microfluidic Control of LNP Size for mRNA

  2026-06-11

  Kim et al. introduce a simulation-based approach to precisely control the size of lipid nanoparticles (LNPs) using microfluidic chip design, demonstrating that LNP size strongly influences mRNA delivery efficiency both in vitro and in vivo. Their findings provide actionable guidance for optimizing LNP-mediated gene delivery systems by decoupling size effects from lipid composition.

• Estradiol Benzoate: Advancing Translational Hormone Research

  2026-06-11

  This thought-leadership article explores the mechanistic foundations and translational strategies for leveraging Estradiol Benzoate as a high-affinity estrogen receptor alpha agonist. By dissecting its biological rationale, experimental validation, and positioning within the competitive landscape, the piece offers actionable guidance for researchers navigating the complexities of estrogen receptor signaling. Strategic perspectives address both immediate laboratory workflows and the broader impact on hormone-dependent disease modeling, while connecting to the latest scientific insights and best practices.

• Veratridine: Voltage-Gated Sodium Channel Opener for Precisi

  2026-06-10

  Veratridine is a gold-standard voltage-gated sodium channel opener, enabling precise control over excitability in neuronal and cancer models. Its robust, reproducible activation of sodium channels makes it indispensable for sodium channel dynamics research, excitotoxicity studies, and high-fidelity screening of sodium channel blockers.

• Mitoxantrone HCl: Dual Mechanisms for Resistance-Proof Resea

  2026-06-10

  Explore Mitoxantrone HCl as a DNA topoisomerase II inhibitor and allosteric nuclear receptor disruptor. This article uniquely examines its dual mechanisms for overcoming therapy resistance and provides deep protocol guidance for translational research.

• Toremifene in Breast Cancer: 20 Years of Clinical Insights

  2026-06-09

  This review synthesizes two decades of clinical data on toremifene, a selective estrogen receptor modulator (SERM), highlighting its safety, efficacy, and role in personalized breast cancer therapy. The findings inform the ongoing optimization of endocrine strategies, with comparative insights relevant to the broader context of steroidal aromatase inhibition.

• PURPL lncRNA Depletion Rejuvenates Senescent Cells via Epige

  2026-06-09

  Wang et al. identify the long non-coding RNA PURPL as a crucial epigenetic regulator driving cellular senescence. Their study demonstrates that targeted depletion of PURPL reverses hallmark features of ageing in human cells, revealing a potential pathway for therapeutic rejuvenation.

• TSPAN18 Protects STIM1 to Promote Bone Metastasis in Prostat

  2026-06-08

  Zhou et al. uncover a novel mechanism in prostate cancer bone metastasis, demonstrating that TSPAN18 stabilizes STIM1 by shielding it from TRIM32-mediated ubiquitination. This discovery reveals a previously unrecognized regulatory axis in calcium signaling, offering new therapeutic targets for advanced prostate cancer.

• Oleanolic Acid in Dual-Loaded Liposome Design: Analytical Br

  2026-06-08

  Explore how Oleanolic acid advances dual-loaded liposome research through inducible nitric oxide synthase induction and innovative encapsulation efficiency analytics. This in-depth guide reveals new strategies for immune response modulation and practical assay optimization.

• ECL Chemiluminescent Substrate Kit: Precision in Translation

  2026-06-07

  Explore how the ECL Chemiluminescent Substrate Detection Kit enables sensitive protein and nucleic acid detection in translational oncology, bridging molecular discovery with clinical innovation. This article reveals unique insights into Western blot chemiluminescence detection, protocol nuances, and practical assay decisions, grounded in the latest scientific advances.

• Silybin A (SKU N1711): Optimizing Cell-Based Assays & Hepato

  2026-06-06

  This article provides scenario-driven, evidence-based guidance for researchers using Silybin A (SKU N1711) in cell viability, cytotoxicity, and metabolic studies. Drawing on validated protocols and real workflow challenges, we demonstrate how this high-purity natural antioxidant from APExBIO delivers reproducible, reliable results in liver disease and oxidative stress research.

• In Vitro Pharmacodynamics of Macrolides Against MmmSC

  2026-06-05

  This study characterizes the in vitro activity and pharmacodynamic profiles of gamithromycin, tylosin, and tilmicosin against Mycoplasma mycoides subspecies mycoides Small Colony (MmmSC), the causative agent of contagious bovine pleuropneumonia. The findings reveal substantial differences in macrolide efficacy across biological matrices, with practical implications for both veterinary infectious disease management and broader antibiotic pharmacology.

• Q-VD(OMe)-OPh in Translational Apoptosis Research: Beyond In

  2026-06-05

  Explore how Q-VD(OMe)-OPh advances apoptosis research as a highly selective caspase inhibitor. This article reveals unique mechanistic insights and practical assay considerations that set it apart from legacy inhibitors.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: Evide

  2026-06-04

  This article examines the identification of moesin (MSN) as a novel biomarker for endothelial injury in sepsis, based on comprehensive clinical and experimental models. The findings offer new insights into sepsis pathophysiology and provide a foundation for improved severity assessment and targeted research into vascular dysfunction.

454 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page